PROBI AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 208 SEK | +1.46% |
|
+0.97% | +2.46% |
| May. 07 | Probi AB Approves Election of Stephanie Blum Sperisen as Board Member | CI |
| May. 07 | Probi AB Approves the Dividend for the Financial Year 2023 | CI |
Presentation Operator MessageOperator (Operator)Welcome to the Probi AB Q3 Report 2021. [Opera...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Companyâs activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Sector
Pharmaceuticals
Calendar
2024-07-16
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.46% | 216M | |
| +30.38% | 684B | |
| +28.96% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +15.98% | 240B | |
| +9.38% | 208B | |
| -7.44% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- PROB Stock
- News Probi AB
- Transcript : Probi AB, Q3 2021 Earnings Call, Oct 22, 2021